Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
Work
Year: 2017
Type: article
Abstract: The goal of this randomized, blinded, crossover clinical trial was to determine whether Nuedexta (dextromethorphan and quinidine) enhanced speech, swallowing, and salivation in patients with ALS. Sixt... more
Source: Neurotherapeutics
Institutions Center for Neurologic Study, Cleveland Clinic, MedStar Georgetown University Hospital, Georgetown University, Providence Center +7 more
Cites: 35
Cited by: 93
Related to: 10
FWCI: 6.87
Citation percentile (by year/subfield): 99.99
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $4,990
Funder ALS Association
Grant ID Treat ALS Award